WILLIAM MITCH to Ubiquitin-Protein Ligases
This is a "connection" page, showing publications WILLIAM MITCH has written about Ubiquitin-Protein Ligases.
Connection Strength
0.380
-
Mechanisms Regulating Muscle Protein Synthesis in CKD. J Am Soc Nephrol. 2020 11; 31(11):2573-2587.
Score: 0.139
-
Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. J Biol Chem. 2015 Apr 24; 290(17):11177-87.
Score: 0.096
-
Malnutrition is an unusual cause of decreased muscle mass in chronic kidney disease. J Ren Nutr. 2007 Jan; 17(1):66-9.
Score: 0.054
-
Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients. JCI Insight. 2017 11 16; 2(22).
Score: 0.029
-
Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Int J Biochem Cell Biol. 2013 Oct; 45(10):2333-47.
Score: 0.021
-
Angiotensin II upregulates protein phosphatase 2Ca and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting. Hypertension. 2011 Oct; 58(4):643-9.
Score: 0.019
-
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest. 2005 Feb; 115(2):451-8.
Score: 0.012
-
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004 Jan; 18(1):39-51.
Score: 0.011